In Part II of this blog series we look at recent transactions in the arena of contract research organization, with a particular focus on private equity investing in CROs.

In one recent example, prescription drug data-mining company IMS Health acquired…

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part II

Contract research organizations (CRO) provide research services support for the biotechnology, medical device and pharmaceutical industries on a contractual basis. They offer such services as preclinical and clinical research, clinical trials management, biopharmaceutical development and pharmacovigilance. CROs run the gamut …

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part I

PPD/Pharmaceutical Product Development, an international contract research firm that has just been named to the 2011 InformationWeek 500, is being taken private by affiliates of the Carlyle Group and Hellman & Friedman in a cash deal valued at …

Continue Reading Contract Research Organizations (CROs) Go Private; Another Segment of Opportunity for Investors?